Skip Navigation LinksHome > September 2013 - Volume 14 - Issue 7 > Oral Triiodothyronine Normalizes Triiodothyronine Levels Aft...
Pediatric Critical Care Medicine:
doi: 10.1097/PCC.0b013e3182917f87
Cardiac Intensive Care

Oral Triiodothyronine Normalizes Triiodothyronine Levels After Surgery for Pediatric Congenital Heart Disease*

Marwali, Eva M. MD1; Boom, Cindy E. MD, PhD1; Sakidjan, Indriwanto MD, PhD2; Santoso, Anwar MD, PhD2; Fakhri, Dicky MD3; Kartini, Ay MD4; Kekalih, Aria MD5; Schwartz, Steven M. MD6; Haas, Nikolaus A. MD, PhD7

Collapse Box

Abstract

Objectives: This study was conducted to determine if oral triiodothyronine supplementation could prevent the decrease of serum triiodothyronine levels that commonly occurs after cardiopulmonary bypass for pediatric congenital heart surgery. Secondary objectives included identifying any significant adverse effects of oral triiodothyronine supplementation, including any effects on the thyroid/pituitary axis.

Design: Randomized, placebo-controlled, doubleblind clinical trial

Setting: Operating room and ICU.

Subjects: Infants and children younger than 2 years of age undergoing congenital heart surgery using cardiopulmonary bypass (n = 43).

Interventions: Subjects were assigned to placebo (n = 15, group A) or one of two treatment groups: a low-dose group (group B, n = 14, 0.5 mcg/kg triiodothyronine orally every 24 hr for 3 d) or a high-dose group (group C, n = 14, 0.5 mcg/kg triiodothyronine orally every 12 hr for 3 d).

Measurements and Main Results: Thyroid hormone, including total and free triiodothyronine levels at predetermined time points, potential side effects indicatinghyperthyroidism, indicators of the thyroid-pituitary axis, and clinicalendpoints. Oral triiodothyronine supplementation twice-daily maintainedserum triiodothyronine levels within normal limits in groupC, whereas serum levels progressively declined in groups A and B. A statistically significant difference in triiodothyronine levels between the treatment groups occurred between 18 and 36 hourspost cross-clamp release, with the largest difference in serum levelsbetween group C and group A noted at 36 hours post cross-clamprelease (total triiodothyronine, 0.71 ± 0.15 [0.34–1.08] ng/mL [p < 0.01]; free triiodothyronine, 2.56 ± 0.49 [1.33–3.79] pg/mL [p < 0.01]). There was no evidence of hyperthyroidism or suppressionof the pituitary-thyroid axis in either treatment group

Conclusions: Oral triiodothyronine supplementation at a dose of 0.5 mcg/kg every 12 hours for 3 days can maintain total and free triiodothyronine levels within normal limits after open-heart surgery using cardiopulmonary bypass for congenitalheart disease.

©2013The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.